GRAMANTIERI, LAURA
GRAMANTIERI, LAURA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Personale esterno ed autonomi
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
2024 Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C.
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC
2024 Arleo, Andrea; Montagner, Annapaola; Giovannini, Catia; Suzzi, Fabrizia; Piscaglia, Fabio; Gramantieri, Laura
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
2024 Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies
2024 Montagner, Annapaola; Arleo, Andrea; Suzzi, Fabrizia; D'Assoro, Antonino B.; Piscaglia, Fabio; Gramantieri, Laura; Giovannini, Catia
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
2023 Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariarosaria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
2023 Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
2022 Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C.
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
2022 Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri
MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much s missing?
2022 Gramantieri Laura; Fornari Francesca
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
2022 Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trere
Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma
2022 Fornari Francesca; Gramantieri Laura
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
2021 Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers
2021 Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F.
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
2021 Gramantieri, L; Giovannini, C; Piscaglia, F; Fornari, F
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas
2021 Giovannini C.; Fornari F.; Piscaglia F.; Gramantieri L.
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2020 Casadei-Gardini A; Marisi G; Dadduzio V; Gramantieri L; Faloppi L; Ulivi P; Foschi F G; Tamburini E; Vivaldi C; Rizzato M D; Ielasi L; Canale M; Conti F; Rudnas B; Fornaro L; Silvestris N; Silletta M; Cardellino G G; Lonardi S; Fornari F; Orsi G; Rovesti G; Zagonel V; Cascinu C; Scartozzi M
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3)
2020 Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A.
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma
2020 Giovannini C.; Fornari F.; Indio V.; Trere' D.; Renzulli M.; Vasuri F.; Cescon M.; Ravaioli M.; Perrucci A.; Astolfi A.; Piscaglia F.; Gramantieri L.
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma
2020 Gramantieri L.; Pollutri D.; Gagliardi M.; Giovannini C.; Quarta S.; Ferracin M.; Casadei-Gardini A.; Callegari E.; De Carolis S.; Marinelli S.; Benevento F.; Vasuri F.; Ravaioli M.; Cescon M.; Piscaglia F.; Negrini M.; Bolondi L.; Fornari F.
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
2020 Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma | Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti... E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C. | 2024-01-01 | EUROPEAN JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | Eur J Immunol - 2023 - Gramantieri - Circulating CD8 lymphocytes predict respo.pdf; eji5648-sup-0001-suppmat.pdf |
| Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC | Arleo, Andrea; Montagner, Annapaola; Giovannini, Catia; Suzzi, Fabrizia; Piscaglia, Fabio; Graman...tieri, Laura | 2024-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | - |
| Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response | Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, C...laudio Stefanelli, Laura Gramantieri, Francesca Fornari | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | Vianello cancers-16-00766_2024.pdf |
| Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies | Montagner, Annapaola; Arleo, Andrea; Suzzi, Fabrizia; D'Assoro, Antonino B.; Piscaglia, Fabio; Gr...amantieri, Laura; Giovannini, Catia | 2024-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | - |
| Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma | Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariaro...saria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Cancers 2023.pdf |
| MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma | Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, C...amelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca | 2023-01-01 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | miR-494 metabolism.pdf; 23498179.zip |
| Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area | Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D...'errico A.; Piscaglia F.; Giovannini C. | 2022-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | 86. adducts.pdf; nutrients-14-01652-s001.zip |
| Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research | Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri | 2022-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | JHC-347946-animal-models-of-hepatocellular-carcinoma--current-applicati.pdf |
| MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much s missing? | Gramantieri Laura; Fornari Francesca | 2022-01-01 | ONCOSCIENCE | - | 1.04 Replica / breve intervento (e simili) | - |
| MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma | Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trere | 2022-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | biomolecules-12-00930.pdf |
| Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma | Fornari Francesca; Gramantieri Laura | 2022-01-01 | - | Elsevier | 2.01 Capitolo / saggio in libro | - |
| Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions | Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L | 2021-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | Elucidating the Molecular Basis of Sorafenib 2021.pdf |
| Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers | Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | Hepatic Cancer Stem Cells 2021.pdf |
| MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma | Gramantieri, L; Giovannini, C; Piscaglia, F; Fornari, F | 2021-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | MicroRNAs as Modulators of Tumor Metabolism 2021.pdf |
| Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas | Giovannini C.; Fornari F.; Piscaglia F.; Gramantieri L. | 2021-01-01 | CELLS | - | 1.01 Articolo in rivista | Notch Signaling Regulation in HCC 2021.pdf |
| Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study | Casadei-Gardini A; Marisi G; Dadduzio V; Gramantieri L; Faloppi L; Ulivi P; Foschi F G; Tamburini... E; Vivaldi C; Rizzato M D; Ielasi L; Canale M; Conti F; Rudnas B; Fornaro L; Silvestris N; Silletta M; Cardellino G G; Lonardi S; Fornari F; Orsi G; Rovesti G; Zagonel V; Cascinu C; Scartozzi M | 2020-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | h_11585_851049 aam con copertina.pdf; 10780432ccr193897-sup-233183_4_supp_6251099_q98ccw (1).docx |
| Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) | Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Graman...tieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A. | 2020-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma | Giovannini C.; Fornari F.; Indio V.; Trere' D.; Renzulli M.; Vasuri F.; Cescon M.; Ravaioli M.; P...errucci A.; Astolfi A.; Piscaglia F.; Gramantieri L. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-12-02674.pdf; cancers-12-02674-s001.pdf |
| MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma | Gramantieri L.; Pollutri D.; Gagliardi M.; Giovannini C.; Quarta S.; Ferracin M.; Casadei-Gardini... A.; Callegari E.; De Carolis S.; Marinelli S.; Benevento F.; Vasuri F.; Ravaioli M.; Cescon M.; Piscaglia F.; Negrini M.; Bolondi L.; Fornari F. | 2020-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | benevento.pdf; 00085472can190472-sup-216842_4_supp_6039954_q4pgpn.doc; 00085472can190472-sup-216842_4_supp_6039958_q4ny44.doc; 00085472can190472-sup-216842_4_supp_6040014_q4khxv.doc |
| Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma | Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Graman...tieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A. | 2020-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |